0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
17.03%
Positive gross profit growth while 0259.HK is negative. John Neff would see a clear operational edge over the competitor.
39.17%
EBIT growth below 50% of 0259.HK's 189.17%. Michael Burry would suspect deeper competitive or cost structure issues.
39.17%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
12.12%
Positive net income growth while 0259.HK is negative. John Neff might see a big relative performance advantage.
13.73%
Positive EPS growth while 0259.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
13.73%
Positive diluted EPS growth while 0259.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.45%
Share reduction while 0259.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.36%
Reduced diluted shares while 0259.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while 0259.HK stands at 100.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-140.53%
Negative OCF growth while 0259.HK is at 466.22%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-128.18%
Negative FCF growth while 0259.HK is at 202.59%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
48403.57%
10Y revenue/share CAGR above 1.5x 0259.HK's 97.87%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
21.62%
5Y revenue/share CAGR 1.25-1.5x 0259.HK's 17.95%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
2.09%
Positive 3Y CAGR while 0259.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-54872.48%
Negative 10Y OCF/share CAGR while 0259.HK stands at 42.84%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-12824.71%
Negative 5Y OCF/share CAGR while 0259.HK is at 8.87%. Joel Greenblatt would question the firm’s operational model or cost structure.
-708.35%
Negative 3Y OCF/share CAGR while 0259.HK stands at 22.18%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
231.68%
Below 50% of 0259.HK's 524.77%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
3699.57%
5Y net income/share CAGR above 1.5x 0259.HK's 65.34%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
574.70%
3Y net income/share CAGR above 1.5x 0259.HK's 58.73%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
96.16%
Positive 5Y equity/share CAGR while 0259.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
39.07%
3Y equity/share CAGR at 50-75% of 0259.HK's 56.60%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 300.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-23.04%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
15.68%
Inventory growth well above 0259.HK's 12.79%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-13.03%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
7.65%
BV/share growth above 1.5x 0259.HK's 2.21%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
2122.61%
Debt growth far above 0259.HK's 192.31%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-25.80%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
25.32%
We expand SG&A while 0259.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.